1. Home
  2. NKTX vs EAF Comparison

NKTX vs EAF Comparison

Compare NKTX & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$2.93

Market Cap

198.2M

Sector

Health Care

ML Signal

HOLD

Logo GrafTech International Ltd.

EAF

GrafTech International Ltd.

HOLD

Current Price

$6.06

Market Cap

183.6M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
EAF
Founded
2015
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
198.2M
183.6M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
NKTX
EAF
Price
$2.93
$6.06
Analyst Decision
Strong Buy
Hold
Analyst Count
4
5
Target Price
$11.33
$11.75
AVG Volume (30 Days)
794.4K
369.1K
Earning Date
05-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
11.88
N/A
EPS
N/A
N/A
Revenue
N/A
$504,134,000.00
Revenue This Year
N/A
$4.25
Revenue Next Year
N/A
$12.49
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$0.93
52 Week High
$3.72
$20.32

Technical Indicators

Market Signals
Indicator
NKTX
EAF
Relative Strength Index (RSI) 48.54 38.09
Support Level $2.50 $4.92
Resistance Level $3.29 $7.73
Average True Range (ATR) 0.31 0.68
MACD 0.03 -0.05
Stochastic Oscillator 22.91 34.12

Price Performance

Historical Comparison
NKTX
EAF

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About EAF GrafTech International Ltd.

GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products used as raw material in the production of graphite electrodes.

Share on Social Networks: